Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

FDA and Justice Department Address Drug Quality Concerns

More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Feb 2, 2012

More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.

Budget Crunch, Political Battles Shape Policy Agenda for Year

Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
Jan 2, 2012

Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.

FDA Revamps to Meet New Challenges

Added responsibilities and outside concerns prompt overhaul of agency's structure.
Dec 2, 2011

Added responsibilities and outside concerns prompt overhaul of agency's structure.

Drug Shortages Create Crisis for Manufacturers, Regulators

Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
Nov 2, 2011

Clamor mounts over compromised care and rising costs due to lack of crucial therapies.

Global Health Challenges Spur Vaccine Development

Manufacturers fund research and reduce prices to tackle diseases.
Oct 2, 2011

Manufacturers fund research and reduce prices to tackle diseases.

Washington Report: Manufacturers and FDA Gear Up for User-Fee Action

PDUFA renewal legislation sets stage for new policies affecting revenue, research, and oversight.
Sep 2, 2011

PDUFA renewal legislation sets stage for new policies affecting revenue, resarch, and oversight.

Washington Report: FDA Maps Strategy to Counter Supply-Chain Threats

Rising imports and overseas production spur realignment of enforcement.
Aug 2, 2011

Rising imports and overseas production spur realignment of enforcement.

FDA and Manufacturers Ponder Biosimilars Pathway

Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.
Jul 2, 2011

Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.

Safety Concerns and Shortages Challenge Pharma

Industry struggles to curb drug abuse, diversion, and disruptions in supply.
Jun 2, 2011

Industry struggles to curb drug abuse, diversion, and disruptions in supply.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here